green
Positive treatment
2.8 score
Treatment trajectory · 1999 → 2026 · click a year to view as-of
1999
2012
2026
Top citers, strongest first. 3 distinct citers.
How cited ↗
discussed
Cited "see"
United States v. Bobby Marshall Zidell
(2×)
See United States v. Thomas, 74 F.3d 701, 709 (6th Cir.), cert. denied, 519 U.S. 820 , 117 S.Ct. 74 , 136 L.Ed.2d 33 (1996).
cited
Cited "see"
In Re Phoenix Petroleum Co.
See generally Moore v. Valder, 65 F.3d 189 , 195 n. 9 (D.C.Cir.1995), cert. denied, 519 U.S. 820 , 117 S.Ct. 75 , 136 L.Ed.2d 35 (1996). 5 .
discussed
Cited "see"
Korshin v. Benedictine Hospital
“Regardless of any substantive violation of the Sherman Act, ... plaintiffs [are still required] to establish that the defendants engaged in anticompetitive conduct that caused them an antitrust injury.” Id.; see Levine v. Central Florida Medical Affiliates, Inc., 864 F.Supp. 1175 (M.D.Fla.1994), aff'd, 72 F.3d 1538 (11th Cir.1996), cert. denied, 519 U.S. 820 , 117 S.Ct. 75 , 136 L.Ed.2d 34 (1996).
Retrieving the full opinion text from the archive…
Thomas et ux.
v.
United States
v.
United States
No. 95-1992.
Supreme Court of the United States.
Oct 7, 1996.
Published
C. A. 6th Cir. Certiorari denied.